Gynecological inflammation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18-85 years old, have sexual history, but no sexual life 3 days before examination; 2. Single or multiple types of HR-HPV infection; 3. Non-menstruation, pregnancy or lactation; 4. No cervical lesions; 5. No history of gynecological tumor; 6. Follow the voluntary principle to participate in the experiment and sign the informed consent form; 7. They did not receive any anti-HPV treatment within 4 weeks before entering the group.
Exclusion criteria
Exclusion criteria: 1. The subjects took contraceptive, antibiotics, immunosuppressants, and other drugs 3 days before the examination; 2. The subjects were in the stage of acute inflammation (trichomonal vaginitis, candidal vaginitis, bacterial vaginosis, Mycoplasma infection, chlamydia infection, etc.); 3. Patients with LSIL or more cervical lesions were diagnosed by histopathological examination; 4. Those who have child-bearing requirements or are in pregnancy or lactation in the past six months; 5. Patients with severe primary diseases such as severe liver and kidney diseases and hematopoietic system; 6. Suffering from mental illness and unable to collaborate; 7. Those with a history of multiple drug or food allergies; 8. Patients with cervical polyps, previous cervical trauma, or physiotherapy for cervical lesions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HPV;Vaginal microecology;Cervical microflora; | — |
Countries
China
Contacts
Maoming Traditional Chinese Medicine Hospital